Protein Chip - Market Insights, Competitive Landscape, and Market Forecast - 2030

Protein Chips Market By Technology (Analytical Protein Microarrays, Functional Protein Microarrays, And Reverse-Phase Protein Arrays), Applications (Genomics & Proteomics, Drug Discovery, And Antibody Characterization), End-Users (Pharmaceutical & Biotechnology Companies, And Academic & Research Institutions), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of chronic disorders, growing applications of protein biochips in various clinical research studies

The protein chips market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders will drive the market for protein chips as there is a growing research and development efforts to understand these diseases better and develop new treatments. Additionally, various applications provided by protein chips in various clinical research studies, is another contributing factor propelling the market growth during the forecast period from 2024 to 2030.

Protein Chips Market Dynamics

According to the latest data provided by the Global Cancer Observatory, in 2022, the estimated number of new cancer cases globally was 20 million, with projections indicating a rise to 32.6 million cases by 2045. Additionally, as per the same source the new cases of cancer in Europe was 4.47 million, with projection estimating a rise to 5.48 million cases by 2045. Additionally, as per the recent data provided by British Heart Foundation (2024), in 2021 there were around 620 million people living with cardiovascular disease globally.

Furthermore, as per the recent data provided by the International Diabetes Federation, in 2021 approximately 537 million adults (20-79 years) were living with diabetes. The total number of people living with diabetes was projected to rise to 643 million by 2030 and 783 million by 2045.

Therefore, the growing prevalence of chronic conditions like cancer, diabetes, and cardiovascular diseases considerably enhances the market for protein chips, mainly due to their increasing usage in healthcare research and development. Protein chips, with their capability to analyze numerous proteins simultaneously, provide a powerful tool for researchers to study disease mechanisms at a molecular level. This facilitates the identification of novel biomarkers, enabling early diagnosis and the development of targeted therapies. Furthermore, the ability of protein chips to conduct high-throughput screenings accelerates drug discovery and development processes, allowing researchers to quickly assess the efficacy and safety of new drug candidates thereby boosting the market of protein chips.

However, the use of alternative technologies such as mass spectroscopy, next generation sequencing, western blotting, and complexity in protein interaction may result in slight obstacle to the growth of protein chips market.

Protein Chips Market Segment Analysis:

Protein Chips Market by Technology (Analytical Protein Microarrays, Functional Protein Microarrays, and Reverse-Phase Protein Arrays), Applications (Genomics & Proteomics, Drug Discovery, and Antibody Characterization), End-Users (Pharmaceutical & Biotechnology Companies and Academic & Research Institutions), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the protein chip market, the genomics and proteomics category is estimated to mass a significant revenue share in the protein chips market in 2023. The application of genomics and proteomics has been instrumental in driving the growth and dominance of the protein biochip market. Genomics enables the identification of genetic variations associated with diseases, guiding the development of personalized therapies and the discovery of biomarkers. Proteomics, on the other hand, provides insights into the expression, structure, and function of proteins, crucial for understanding disease mechanisms and drug targets. Protein biochips, which allow for high-throughput protein analysis, are integral to both genomics and proteomics research by enabling rapid and simultaneous detection of multiple proteins. This integration enhances diagnostic accuracy, facilitates drug discovery, and supports personalized medicine initiatives, thereby expanding the protein biochip market significantly.

The growth is further propelled by ongoing advancements and collaborations in protein biochip technology in the field of proteomics and genomics applications, making disease diagnosis faster, more reliable, and more accessible, thereby broadening their adoption in clinical settings and research laboratories worldwide. For instance, In September 2022, Illumina Inc. launched the NovaSeq X Series, enabling faster and more powerful sustainable sequencing. The revolutionary new technology, NovaSeq X Plus could generate 20,000+ whole genomes per year, therefore accelerating genomic discovery and clinical insights to transform patient lives. Thus, such developments across the globe are driving the growth of the biochips market in the region. As a result, the demand for protein biochips is expected to increase, driving market growth and adoption in both research and clinical settings.

Accordingly, based on the factors mentioned above, the genomics and proteomics category is expected to experience significant growth. This growth will drive the overall protein chips market during the forecast period.

North America Is Expected To Dominate The Overall Protein Chips Market:

North America is expected to account for the highest proportion of the protein chips market in 2023, out of all regions. One of the primary drivers is the escalating prevalence of chronic disease such as cancer and cardiovascular. Additionally, the presence of major pharmaceutical and biotechnology players in the region, along with the presence of advanced research and development infrastructure. Further, increasing collaborations between academia, research institutions, and biotechnology companies are some of the factors propelling the growth of the protein chips market in North America.

According to recent data from the GLOBOCAN, in 2022, North America saw an estimated 2.67 million new cases of cancer, with forecasts indicating a rise to 3.83 million by 2045. As per the same source, in Canada, the number of new cancer cases was around 292,000 in 2022, projected to reach 449,000 by 2045. Meanwhile, in Mexico, there were approximately 207,000 new cases of cancer in 2022, expected to increase to 360,000 by 2045.

Additionally, as per the recent data provided by British Heart Foundation (2024), in 2021 there were around 48 million people living with cardiovascular disease in North America.

According to the latest report provided by the Centre of Disease Control and Prevention, in 2021 estimates indicated that 38.4 million people of all ages, or 11.6% of the U.S. population, had diabetes. Additionally 38.1 million individuals aged 18 years and older, representing 14.7% of all U.S. adults, were affected by diabetes in 2021.

As the surge of chronic disorders increases there is a significant increase in the research and development efforts to understand these diseases better and develop new treatments. Protein chips are crucial in this research as they allow for high-throughput analysis of protein interactions and functions, accelerating discoveries and innovations.

The growth is further propelled by ongoing acquisitions among the companies in protein biochip technology. For instance, in March 2023, Spectrum Solutions(R) acquired Alimetrix, Inc., a lab accredited by CLIA and CAP that specializes in creating custom diagnostic tests, and Microarrays, Inc., a company known for its array-based biological research tools like gene expression and protein arrays. Thus, this expanded product portfolio will cater to a wider range of applications in both biological research and clinical diagnostics, thereby increasing market reach.

Thus, the above mentioned factors are expected to escalate the market of protein chips in North America during the forecast years.

Protein Chips Market Key Players:

Some of the key market players operating in the Protein Chips market include Agilent Technologies, Inc., RayBiotech, Inc., Sengenics Corporation LLC., CDI Labs., Creative Biolabs., Proteintech Group, Inc, RayBiotech Life Inc., QUOTIENT LIMITED, PerkinElmer Inc., Merck KGAA, Illumina Inc., Arrayit Corporation, Spectrum Solutions, ACROBiosystems, Sengenics Corporation LLC, and others.

Recent Developmental Activities In The Protein Chips Market:

• In January 2024, Agilent Technologies launched the ProteoAnalyzer system, an advanced automated system for protein analysis using parallel capillary electrophoresis. This new platform makes it easier and more efficient to analyze complex protein mixtures. It is useful in various fields, including pharmaceuticals, biotechnology, food analysis, and academic research.
• In December 2023, Theralink Technologies announced groundbreaking research by George Mason University and the University of California, San Francisco, published in Cell Reports Medicine. The study used Theralink's RPPA (reverse phase protein array) technology to analyze tumors from over 700 breast cancer patients. It discovered a protein biomarker called HARPS, which can help better treat Triple Negative Breast Cancer (TNBC) by identifying appropriate therapies, leading to an 80% response rate compared to the current 30-40%.

Key Takeaways From The Protein Chips Market Report Study

• Market size analysis for current protein chips size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the protein chips market.
• Various opportunities available for the other competitors in the protein chips market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current protein chips market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for protein chips market growth in the coming future?

Target Audience Who Can Be Benefited From This Protein Chips Market Report Study

• Protein chips product providers
• Research organizations and consulting companies
• Protein chips -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in protein chips
• Various end-users who want to know more about the protein chips market and the latest technological developments in the protein chips market.

Frequently Asked Questions For The Protein Chips Market:

1. What are protein chips?

Protein chips, also known as protein microarrays, are sophisticated laboratory tools designed to study a vast array of proteins simultaneously. These chips consist of a solid surface, typically a glass slide or membrane, onto which thousands of different proteins are immobilized. They facilitate the high-throughput analysis of protein expression, interactions, activities, and functions, making them invaluable in various fields such as biomarker discovery, drug development, disease diagnostics, and functional proteomics.

2. What is the market for Protein Chips?

The protein chips market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the protein chips market?

The demand for protein chips is primarily being boosted by the growing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders. Additionally, growing applications of protein biochips in various clinical research studies is another major driver for the growth of the protein chips market during the forecast years.

4. Who are the key players operating in the protein chips market?

Some of the key market players operating in the protein chips are Agilent Technologies, Inc., RayBiotech, Inc., Sengenics Corporation LLC., CDI Labs., Creative Biolabs., Proteintech Group, Inc, RayBiotech Life Inc., QUOTIENT LIMITED, PerkinElmer Inc., Merck KGAA, Illumina Inc., Arrayit Corporation, Spectrum Solutions, ACROBiosystems, Sengenics Corporation LLC, and others.

5. Which region has the highest share in the protein chips market?

North America is expected to account for the highest proportion of the protein chips market in 2023, out of all regions. One of the primary drivers is the escalating prevalence of chronic disease such as cancer and cardiovascular. Additionally, the presence of major pharmaceutical and biotechnology players in the region, along with the presence of advanced research and development infrastructure. Further, increasing collaborations between academia, research institutions, and biotechnology companies are some of the factors propelling the growth of the protein chips market in North America.